Enabler of Biopharmaceutical collaboration
Vespa Capital exited BioPhorum in 2021
BioPhorum is a cross industry collaboration group connecting most of the world's largest biopharmaceutical manufacturers and suppliers to solve pertinent pre-competitive industry challenges and improve operational best practices.
BioPhorum creates an environment where biopharmaceutical companies can collaborate for the benefit of all. This is particularly important given the complexities and high costs involved in manufacturing biopharmaceutical drugs.
BioPhorum facilitates eight forums (“Phorums”) across the biopharmaceutical value chain - Drug Substance, Drug Development, Fill Finish, Technology Roadmap, Supply Partner, Information Technology, MedTech and Cell & Gene Therapy.
Enviable levels of deep engagement with a range of companies operating across the biopharmaceutical value chain, including 25 of the 25 largest biopharmaceutical firms.
Members collaborate to drive development at the cutting edge of biopharmaceutical manufacturing. In 2018 BioPhorum led the production of the Cell & Gene Therapy for the industry and in 2020 incubated a Phorum to focus on MedTech.
When we were looking for an investment partner to help us go to the next stage of our development, we wanted constructive engagement not interference, experience in areas that were new to us and a passion for the life sciences industry that matched our own. In Vespa Capital we found all these things.Simon Chalk, Director, BioPhorum